1) Micro-nanospheres
微纳米球
2) nanosphere
纳米微球
1.
Studies on cetyl-chitosan nanosphere as carriers for paclitaxel;
十六烷基壳聚糖纳米微球负载紫杉醇的研究
2.
Preparation and Characterization of PS/TiO2 Composite Nanospheres;
PS/TiO_2复合纳米微球的制备和结构表征
3.
Study on Encapsulation of Plasmid DNA in Poly(Ethylene Glycol)-Poly(Benzyl L-Glutamate) Copolymer Nanospheres and its Characteristics in Vitro;
转基因载体聚乙二醇-聚谷氨酸纳米微球的制备
3) nanoparticle
纳米微球
1.
The Preparation of Berbamine-paclitaxel Nanoparticles and Evaluation of Its Synergistic Antitumor Effect in Vitro
小檗胺与紫杉醇纳米微球的构建及其体外协同抑瘤效应评价
2.
Preparation and evaluation of alginate nanoparticle simultaneous delivery of doxorubicin and Tf antibody
人转铁蛋白修饰海藻酸钠载阿霉素纳米微球的制备与表征
3.
The new approach for the preparation of the MAF/PCL micelles by self-assembly of a core-shell structure in aqueous solution with PFA chain fragment and PCL as the core and PAA chain fragment in MAF to form complex nanosize micelles and can be further crosslinked to get core-shell structure nanoparticles.
将MAF与可生物降解均聚物聚己内酯(PCL)在水溶液中进行自组装,形成以MAF中PFA链段与PCL为核、MAF中PAA链段为壳的核壳结构复合纳米胶束,进一步对PAA壳进行化学交联,最终得到具有核壳结构的复合纳米微球。
4) Nanoparticles
纳米微球
1.
Preparation and Self-assembly on Glasses of Surface-functional Polystyrene Nanoparticles;
表面功能化聚苯乙烯纳米微球的制备及自组装
2.
Study on preparation of cetyl chitosan nanoparticles as paracetamol carrier;
壳聚糖烷基化改性及其纳米微球负载扑热息痛的研究
3.
Effects of recombinant human bone morphogenetic-2 polybutylcyanoacrylate nanoparticles on proliferation and differentiation of cultured bone mesenchymal stem cells;
重组人骨形成蛋白-2聚氰基丙烯酸正丁酯纳米微球缓释系统对骨髓间充质干细胞增殖分化影响的实验研究
5) nanospheres
纳米微球
1.
Preparation of ADM-PLGA sustained release nanospheres and their release characteristics in vitro;
ADM-PLGA缓释纳米微球的制备及体外释药的研究
2.
Stable nanospheres with antimicrobial activity via template polymerization;
模板聚合法制备稳定的抗菌性纳米微球
3.
Hollow superparamagnetic Fe3O4 nanospheres were prepared by co-precipitating iron (Ⅱ) and iron (Ⅲ) chloride salts in the presence of sodium hydroxide at 80℃.
利用聚氧乙烯-聚氧丙烯-聚氧乙烯嵌段共聚物F127作为模板采用共沉淀法制备了空心超顺磁性Fe3O4纳米微球并用X射线衍射(XRD)和透射电子显微镜(TEM)进行了表征,纳米微球的大小为55-75nm,壳的厚度为7nm左右,颗粒大小均匀、在水溶液中分散良好。
补充资料：可降解淀粉微球和生物降解白蛋白微球阻滞法
可降解淀粉微球和生物降解白蛋白微球阻滞法
介入放射学技术。介入性局部化疗之前，把二者注入靶动脉，可暂时减少动脉血流，再行化疗药物灌注，以减少血液冲刷，保持局部化疗药物浓度的技术。与其他中期和长期栓塞微球不同，DSM和BAM仅造成数十分钟的血流量减少，待其被降解后血流可恢复至以前水平。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条